Phase II/III trial : Evaluation of Lenalidomide + Cyclophosphamide + Prednisolone combination therapy in multiple myeloma. Project completed as a part of thesis in DM Haematology and submitted to the institute.
Study of JAK2 mutation in patients with splanchnic venous thrombosis. Project completed as a part of theses in DM Haematology and submitted to the institute.
Rathi Shyam ,Mahapatra M, Mishra P, Gupta N, Kapoor R, Pati H. To study efficacy and toxicity of lenalidomide, cyclophosphamide and prednisone combination therapy in multiple myeloma. Oral presentation. Indian society of hematology and transfusion medicine.( annual meeting). Delhi, 2009. Abstract no.032. online IJHBT issue DEC 2009
Rathi Shyam ,Sazawal S, Chikara T, Seth T, Saraya A, Saxena R.
Prevalence of JAK2 mutation in patients with splanchnic vein thrombosis,
AIIMS experience . Indian society of hematology and transfusion
medicine.( annual meeting). Delhi, 2009. Abstract no.078.
Rathi Shyam A., Sazawal S, Bharti Sharma. Role of JAK2 mutation in patients with splanchnic vein thrombosis: AIIMS experience. Abstract no.1017 at the 14th Annual Meeting of European Haematology Association, Berlin, June 2009 (available online at hematologica journal).
Rathi Shyam A., Sazawal S, Bharti Sharma. Evaluation of JAK2 mutation in patients with Splanchnic Venous Thrombosis. Oral presentation. Abstract no.78 at the International Society of Haematology. Bangkok, 2008. (Published in ISH abstract book).
Rathi Shyam. PTLD Management- An overview. Post-transplant lymphoproliferative disorder book 2010.
Rathi Shyam, M Mahapatra. Approach to Polycythemia Vera. Hematology Today book 2010.
Rathi Shyam, Agrawal Narendra. Acquired sideroblastic anemia. Iron disorder book 2010.
Agarwal MB, Rathi Shyam A. Haematological disorders in pregnancy. Medical Disorders in Pregnancy. ECAB Clinical Update. Obstetrics & Gynaecology. Ed-Thanawala U, Diwakar H. Elsevier. 2009. pp 75-96.
Rathi Shyam A. RQ-PCR (including microRNAs) based prognostic scoring system for CLL. Haem Onc (India) : Newsletter. CLL, April 2009.
Agarwal DK, Bhargava R, Dolai T K, Singhal D, Mahapatra M, Rathi Shyam A, Bohra B, Rathod N. An unusual presentation of eosinophilic variant of chronic myeloid leukemia (eoCML).Ann Haematol. 2009;88:89-90
Dolai T K, Kumar R, Bhargava R, Mahapatra M, Mishra P, Seth T, Kar R, Rathi Shyam A, Pati H P, Saxena R, Tyagi S, Multiorgan failure due to Mycobacterium tuberculosis and Aspergillus flavus infection after allogeneic bone marrow transplantation. Ind J Haemat Blood Trans. 2008;24:78-80.
Bhargava R, Dolai T K, Singhal D, Mahapatra M, Mishra P, Rathod N, Rathi Shyam A. Pure red cell aplasia associated with thymoma: Is thymectomy the cure? Leukemia Research;2008; May 20.(ahead of print). Available online from 21 may 2008.
Agarwal MB, Rathi Shyam A, Rathod N, Subramanian R. Caspofungin : A major breakthrough in treatment of systemic fungal infections. J. Assoc. Phys India. 2006;54:943-8.
Agarwal MB, Rathi Shyam A, Rathi Shonali S. Molecular techniques in
haematological malignancy : From bench to bedside. Haematology Today -
2008. Proceedings of the XIV National CME in Haematology, Mumbai, India.
Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Shyam Rathi and his staff know how they are doing and how they can improve their services.
How was your experience with Dr. Shyam Rathi?
Help other patients, and let the doctor know how he's doing